Gift or transfer — classified separately from trades.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Apr 1, 2026
Reporting period
Not applicable
Filed with the SEC
Apr 3, 2026
CEOIndirect holdingGift / transfer
Context
Classification
gift transfer
Code G — gift, bequest or transfer
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001106578-26-000024
Filed / recorded
Apr 3, 2026, 12:34 AM UTC
Added to OQRO
Oct 6, 2026, 9:34 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
UNITED THERAPEUTICS Corp
Issuer CIK
1082554
Ticker
UTHR
Reporting person
Martine A Rothblatt
Relationship
Director, Officer
Officer title
Chairperson & CEO
Security
Stock Options
Table
Derivative (Table II)
Transaction date
Apr 1, 2026
Transaction code
G
Shares / units
500,000
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
0
Ownership form
Indirect — By Trusts
Amendment
No
Footnotes from the filing
This stock option was gifted from a trust beneficially owned by the Reporting Person to a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries. The gift was made pursuant to an agreement entered into on November 21, 2025 which provided that the number of stock options to be gifted would be based on set formula using a valuation to be conducted on April 1, 2026. The actual number of stock options to be gifted was determined on April 1, 2026 and the gift occurred on the same date. No funds were exchanged, and no sale of shares occurred in the gift.
This stock option become exercisable in three equal annual installments beginning on the second anniversary of the grant date. The stock option was granted on March 15, 2019.